{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:09:25Z","timestamp":1789099765677,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10072-026-09388-4","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:50:29Z","timestamp":1789098629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oligoclonal band count as a marker of MRI lesion burden and clinical profile in newly diagnosed multiple sclerosis"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7888-5396","authenticated-orcid":false,"given":"Yagmur","family":"Inalkac Gemici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0627-8914","authenticated-orcid":false,"given":"Melike","family":"Batum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-1921","authenticated-orcid":false,"given":"Aysegul Seyma","family":"Sar\u0131tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-9824","authenticated-orcid":false,"given":"Ays\u0131n","family":"Kisabay Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2909-1607","authenticated-orcid":false,"given":"Hatice","family":"Mavioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"9388_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD (2021) Diagnosis and treatment of multiple sclerosis: A review. JAMA 325:765\u2013779. https:\/\/doi.org\/10.1001\/jama.2020.26858","journal-title":"JAMA"},{"key":"9388_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"9388_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/jnnp-2012-304695","volume":"84","author":"R Dobson","year":"2013","unstructured":"Dobson R, Ramagopalan S, Davis A, Giovannoni G (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis. J Neurol Neurosurg Psychiatry 84:909\u2013914. https:\/\/doi.org\/10.1136\/jnnp-2012-304695","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9388_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12974-017-0812-y","volume":"14","author":"G Farina","year":"2017","unstructured":"Farina G, Magliozzi R, Pitteri M, Reynolds R, Rossi S, Gajofatto A et al (2017) Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients. J Neuroinflammation 14:40. https:\/\/doi.org\/10.1186\/s12974-017-0812-y","journal-title":"J Neuroinflammation"},{"key":"9388_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70693-9","volume":"10","author":"L Zhao","year":"2020","unstructured":"Zhao L, Abrigo J, Chen Q, Au C, Ng A, Fan P et al (2020) Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands. Sci Rep 10:13703. https:\/\/doi.org\/10.1038\/s41598-020-70693-9","journal-title":"Sci Rep"},{"key":"9388_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.msard.2017.11.005","volume":"19","author":"G Fenu","year":"2018","unstructured":"Fenu G, Lorefice L, Frau J, Coghe G, Marrosu MG, Cocco E et al (2018) Brain volume in early multiple sclerosis patients with and without oligoclonal bands. Mult Scler Relat Disord 19:55\u201358. https:\/\/doi.org\/10.1016\/j.msard.2017.11.005","journal-title":"Mult Scler Relat Disord"},{"key":"9388_CR7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458516674367","volume":"23","author":"L Ruano","year":"2017","unstructured":"Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F et al (2017) Age, disability and cognition in MS. Mult Scler 23:1258\u20131267. https:\/\/doi.org\/10.1177\/1352458516674367","journal-title":"Mult Scler"},{"key":"9388_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S et al (2012) Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler 18:891\u2013898. https:\/\/doi.org\/10.1177\/1352458511431076","journal-title":"Mult Scler"},{"key":"9388_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1212\/WNL.0b013e31824528c9","volume":"78","author":"MP Amato","year":"2012","unstructured":"Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A et al (2012) Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology 78:309\u2013314. https:\/\/doi.org\/10.1212\/WNL.0b013e31824528c9","journal-title":"Neurology"},{"key":"9388_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jns.2005.05.020","volume":"245","author":"RH Benedict","year":"2006","unstructured":"Benedict RH, Zivadinov R (2006) Predicting neuropsychological abnormalities in multiple sclerosis. J Neurol Sci 245:67\u201372. https:\/\/doi.org\/10.1016\/j.jns.2005.05.020","journal-title":"J Neurol Sci"},{"issue":"9\u201310","key":"9388_CR11","first-page":"295","volume":"128","author":"R Zivadinov","year":"2006","unstructured":"Zivadinov R, Sepci\u0107 J (2006) Upotreba magnetske rezonancije u dijagnozi i prognozi multiple skleroze [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis]. Lijec Vjesn 128(9\u201310):295\u2013308","journal-title":"Lijec Vjesn"},{"key":"9388_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.29399\/npa.12667","volume":"55","author":"BP \u00c7inar","year":"2018","unstructured":"\u00c7inar BP, \u00d6zakba\u015f S (2018) Prediction of conversion from clinically isolated syndrome to multiple sclerosis according to baseline characteristics: A prospective study. Noro Psikiyatr Ars 55:15\u201321. https:\/\/doi.org\/10.29399\/npa.12667","journal-title":"Noro Psikiyatr Ars"},{"key":"9388_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.31128\/AJGP-07-21-6103","volume":"51","author":"BS Travers","year":"2022","unstructured":"Travers BS, Tsang BK, Barton JL (2022) Multiple sclerosis: Diagnosis, disease-modifying therapy and prognosis. Aust J Gen Pract 51:199\u2013206. https:\/\/doi.org\/10.31128\/AJGP-07-21-6103","journal-title":"Aust J Gen Pract"},{"key":"9388_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/17562864211030664","volume":"14","author":"P Chaloulos-Iakovidis","year":"2021","unstructured":"Chaloulos-Iakovidis P, Wagner F, Weber L, Diem L, Chan A, Salmen A et al (2021) Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study. Ther Adv Neurol Disord 14:17562864211030664. https:\/\/doi.org\/10.1177\/17562864211030664","journal-title":"Ther Adv Neurol Disord"},{"key":"9388_CR15","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/brain\/awy021","volume":"141","author":"C Matute-Blanch","year":"2018","unstructured":"Matute-Blanch C, Villar LM, \u00c1lvarez-Cerme\u00f1o JC, Rejdak K, Evdoshenko E, Makshakov G et al (2018) Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome. Brain 141:1085\u20131093. https:\/\/doi.org\/10.1093\/brain\/awy021","journal-title":"Brain"},{"key":"9388_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/1352458514568827","volume":"21","author":"J Kuhle","year":"2015","unstructured":"Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J et al (2015) Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Mult Scler 21:1013\u20131024. https:\/\/doi.org\/10.1177\/1352458514568827","journal-title":"Mult Scler"},{"key":"9388_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.07.006","volume":"180","author":"H Link","year":"2006","unstructured":"Link H, Huang YM (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180:17\u201328. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.07.006","journal-title":"J Neuroimmunol"},{"key":"9388_CR18","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s00415-012-6790-1","volume":"260","author":"R Dobson","year":"2013","unstructured":"Dobson R, Giovannoni G (2013) Autoimmune disease in people with multiple sclerosis and their relatives: A systematic review and meta-analysis. J Neurol 260:1272\u20131285. https:\/\/doi.org\/10.1007\/s00415-012-6790-1","journal-title":"J Neurol"},{"key":"9388_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/14737159.2017.1262260","volume":"17","author":"M Gastaldi","year":"2017","unstructured":"Gastaldi M, Zardini E, Franciotta D (2017) An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis. Expert Rev Mol Diagn 17:31\u201346. https:\/\/doi.org\/10.1080\/14737159.2017.1262260","journal-title":"Expert Rev Mol Diagn"},{"key":"9388_CR20","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s10072-015-2303-1","volume":"36","author":"M Anagnostouli","year":"2015","unstructured":"Anagnostouli M, Christidi F, Zalonis I, Nikolaou C, Lyrakos D, Triantafyllou N et al (2015) Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients. Neurol Sci 36:2053\u20132060. https:\/\/doi.org\/10.1007\/s10072-015-2303-1","journal-title":"Neurol Sci"},{"key":"9388_CR21","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1001\/archneur.58.12.2044","volume":"58","author":"JR Avasarala","year":"2001","unstructured":"Avasarala JR, Cross AH, Trotter JL (2001) Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol 58:2044\u20132045. https:\/\/doi.org\/10.1001\/archneur.58.12.2044","journal-title":"Arch Neurol"},{"issue":"1","key":"9388_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207768","volume":"102","author":"A Cagol","year":"2024","unstructured":"Cagol A, Benkert P, Melie-Garcia L, Schaedelin SA, Leber S, Tsagkas C, Barakovic M, Galbusera R, Lu PJ, Weigel M, Ruberte E, Radue EW, Yaldizli \u00d6, Oechtering J, Lorscheider J, D\u2019Souza M, Fischer-Barnicol B, M\u00fcller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb JM, Remonda L, Wagner F, Vargas MI, Du Pasquier RA, Lalive PH, Pravat\u00e0 E, Weber J, Cattin PC, Absinta M, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C (2024) Association of spinal cord atrophy and brain paramagnetic rim lesions with progression independent of relapse activity in people with MS. Neurology 102(1):e207768. https:\/\/doi.org\/10.1212\/WNL.0000000000207768","journal-title":"Neurology"},{"key":"9388_CR23","doi-asserted-by":"publisher","first-page":"106388","DOI":"10.1016\/j.msard.2025.106388","volume":"97","author":"M Batum","year":"2025","unstructured":"Batum M, Sar\u0131ta\u015f A\u015e, Erdo\u011fan B, \u00c7elebi N, Ak AK, Mavio\u011flu H (2025) The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative values with gender, age and education corrections in the Turkish population. Mult Scler Relat Disord 97:106388. https:\/\/doi.org\/10.1016\/j.msard.2025.106388","journal-title":"Mult Scler Relat Disord"},{"key":"9388_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jneuroim.2014.06.010","volume":"274","author":"D Ferreira","year":"2014","unstructured":"Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund LO et al (2014) Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy. J Neuroimmunol 274:149\u2013154. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.06.010","journal-title":"J Neuroimmunol"},{"key":"9388_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.msard.2019.03.027","volume":"31","author":"M Pardini","year":"2019","unstructured":"Pardini M, Gualco L, Bommarito G, Roccatagliata L, Schiavi S, Solaro C et al (2019) CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS. Mult Scler Relat Disord 31:93\u201396. https:\/\/doi.org\/10.1016\/j.msard.2019.03.027","journal-title":"Mult Scler Relat Disord"},{"key":"9388_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-0404.2005.00552.x","volume":"113","author":"I Nakashima","year":"2006","unstructured":"Nakashima I, Fujihara K, Miyazawa H, Nishimura T, Okita N, Takase S et al (2006) Relevance of callosal and periventricular MRI lesions to oligoclonal bands in multiple sclerosis. Acta Neurol Scand 113:125\u2013131. https:\/\/doi.org\/10.1111\/j.1600-0404.2005.00552.x","journal-title":"Acta Neurol Scand"},{"key":"9388_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00415-009-5081-y","volume":"256","author":"HB Huttner","year":"2009","unstructured":"Huttner HB, Schellinger PD, Struffert T, Richter G, Engelhorn T, Bassemir T et al (2009) MRI criteria in MS patients with negative and positive oligoclonal bands: Equal fulfillment of Barkhof\u2019s criteria but different lesion patterns. J Neurol 256:1121\u20131125. https:\/\/doi.org\/10.1007\/s00415-009-5081-y","journal-title":"J Neurol"},{"key":"9388_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4274\/tnd.2022.72558","volume":"28","author":"NK Tutar","year":"2022","unstructured":"Tutar NK, S\u00f6ylemez E, \u00d6merhoca S, Kale \u0130\u00e7en N (2022) The effect of oligoclonal bands in patients with multiple sclerosis. Turk J Neurol 28:217\u2013222. https:\/\/doi.org\/10.4274\/tnd.2022.72558","journal-title":"Turk J Neurol"},{"key":"9388_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59061028","volume":"59","author":"E Aleksandravi\u010di\u016bt\u0117","year":"2023","unstructured":"Aleksandravi\u010di\u016bt\u0117 E, Stankevi\u010di\u016bt\u0117 R, Balnyt\u0117 R, \u0160aknys L, Ulozien\u0117 I (2023) Oligoclonal band status and features of radiological and clinical findings in patients with multiple sclerosis in Lithuania. Medicina (Kaunas) 59:1028. https:\/\/doi.org\/10.3390\/medicina59061028","journal-title":"Medicina (Kaunas)"},{"key":"9388_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jocn.2024.07.013","volume":"126","author":"A Tun\u00e7","year":"2024","unstructured":"Tun\u00e7 A, Sefero\u011flu M, S\u0131vac\u0131 A\u00d6, K\u00f6kt\u00fcrk MD, Akba\u015f AA, Bozkurt B et al (2024) Oligoclonal band count as a marker of disease activity and progression in multiple sclerosis: a multicenter study. J Clin Neurosci 126:353\u2013360. https:\/\/doi.org\/10.1016\/j.jocn.2024.07.013","journal-title":"J Clin Neurosci"},{"key":"9388_CR31","doi-asserted-by":"crossref","unstructured":"Perrone C, Berger J, Markowitz C (2018) Oligoclonal band number correlates with relapses and progression in multiple sclerosis. Consortium of Multiple Sclerosis Centers Annual Meeting; Abstract in Neurology 92, Suppl. P4.2-041","DOI":"10.1212\/WNL.92.15_supplement.P5.2-014"},{"key":"9388_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.678735","volume":"12","author":"N Giedraitiene","year":"2021","unstructured":"Giedraitiene N, Drukteiniene E, Kizlaitiene R et al (2021) Cognitive decline in multiple sclerosis is related to the progression of retinal atrophy and presence of oligoclonal bands: a 5-year follow-up study. Front Neurol 12:678735. https:\/\/doi.org\/10.3389\/fneur.2021.678735","journal-title":"Front Neurol"},{"key":"9388_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/1744666X.2021.1912947","volume":"17","author":"H Tumani","year":"2021","unstructured":"Tumani H, Deisenhammer F, Giovannoni G et al (2021) Oligoclonal bands in multiple sclerosis: An update on methodology and clinical relevance. Expert Rev Clin Immunol 17:431\u2013441. https:\/\/doi.org\/10.1080\/1744666X.2021.1912947","journal-title":"Expert Rev Clin Immunol"},{"key":"9388_CR34","doi-asserted-by":"publisher","first-page":"e2398","DOI":"10.1002\/brb3.2398","volume":"11","author":"C Coll-Mart\u00ednez","year":"2021","unstructured":"Coll-Mart\u00ednez C, Blanco Y, Zubizarreta I et al (2021) Lipid-specific oligoclonal IgM bands predict long-term memory impairment in multiple sclerosis. Brain Behav 11:e2398. https:\/\/doi.org\/10.1002\/brb3.2398","journal-title":"Brain Behav"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09388-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09388-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:50:30Z","timestamp":1789098630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09388-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["9388"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09388-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was reviewed and approved by the Local Ethics Committee of (approval number: 554], date: [25.09.2023]). Due to the retrospective design of the study, the requirement for written informed consent was waived by the ethics committee. All patient data were anonymized prior to analysis.","order":1,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no relevant disclosures.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"773"}}